NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences announced on Tuesday an agreement to collaborate with Wyatt Technology on products, applications, and technical development.

Specifically, the companies will develop products for nanoparticle characterization to be marketed under the Beckman Coulter Life Sciences brand. The deal opens up potential future collaborations on product development and the sharing of business practices, Beckman Coulter Life Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.